Therapeutic applications of soft contact lenses in severe dry eye with chronic graft-versus-host disease

ISRCTN ISRCTN05106737
DOI https://doi.org/10.1186/ISRCTN05106737
Secondary identifying numbers 001
Submission date
30/11/2006
Registration date
19/01/2007
Last edited
14/01/2021
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Junko Ogawa
Scientific

Shinanomachi 35 Shinjuku ku
Keio Univ Sch Med
Dept Ophthalmology
Tokyo
160-8582
Japan

Email junoga1102@yahoo.co.jp

Study information

Study designRetrospective, consisting of chart review of GVHD patients who received therapeutic contact lenses wear. Please note that chart reviews started in September 1, 2006 and will be finalised by spring next year.
Primary study designObservational
Secondary study designSingle-centre
Study setting(s)Hospital
Study typeScreening
Scientific titleTherapeutic applications of soft contact lenses in severe dry eye with chronic graft-versus-host disease
Study objectivesBandage contact lenses have favourable effects on the occular surface disease status in severe dry eye patients with chronic Graft-Versus-Host Disease (cGVHD).
Ethics approval(s)US Food and Drug Administration (FDA) approved contact lens material used for the study. Therapeutic contact lenses are not regarded as medical devices in Japan. According to our regulations, when contact lenses are deemed essential for therapeutic purposes by an ophthalmologist, permission from the university or hospital is not required.
Health condition(s) or problem(s) studiedChronic graft versus host disease
InterventionSilicone hydrogel Contact Lens use. Patients wore contact lenses continuously and
replaced their contact lenses for every week to once in four weeks. Only patients with more than six months of follow up were included.
Intervention typeOther
Primary outcome measurePain relief
Secondary outcome measuresVital staining score
Overall study start date01/09/2006
Completion date30/04/2007

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants10 patients
Total final enrolment7
Key inclusion criteria1. Severe cGVHD dry eye subjects with fibrotic lid changes and trichiasis refractory to treatment with non-preserved artificial tears
2. Autologous serum eye drops
3. Bilateral punctal occlusion
Key exclusion criteria1. Mild cGVHD patients
2. cGVHD
Date of first enrolment01/09/2006
Date of final enrolment30/04/2007

Locations

Countries of recruitment

  • Japan

Study participating centre

Shinanomachi 35 Shinjuku ku
Tokyo
160-8582
Japan

Sponsor information

Ciba Vision (Japan)
Industry

Tennoz Central Tower 13
2-2-24 Higashi Shinagawa
Tokyo
140-0002
Japan

Email junoga1102@yahoo.co.jp
Website http://www.cibavision.jp
ROR logo "ROR" https://ror.org/01k1ftz35

Funders

Funder type

Other

Contact lenses were donated by CIBA vision. Costs incurred by vital staining, and

No information available

slit lamp examinations were covered by social insurance.

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Abstract results results presented at ARVO 01/05/2007 14/01/2021 No No

Editorial Notes

14/01/2021: The following changes have been made:
1. Publication reference added.
2. The final enrolment number has been added from the reference.